Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Boston Convention and Exhibition Center

23 jun 2013 8:30 a.m. - 27 jun 2013 12:45 p.m.

415 Summer Street, , Boston, MA 02210 , USA

DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Science

Session Chair(s)

Nancie E. Celini, DrPH

Nancie E. Celini, DrPH

Chief Health Technology Advisor and Educator

CAB Inc., United States

Learning Objective : Identify the difference between eTMF and TMF management; Define a strategic plan for the eTMF transition; Discuss the benefits, risks and realities of eTMF implementation.

Speaker(s)

Betsy  Fallen, RN

Panelist

Betsy Fallen, RN

BAFallen Consulting LLC, United States

Consultant

Graeme  Currie, PHD

Panelist

Graeme Currie, PHD

Regeneron Pharmaceuticals, United States

Head, Clinical Project Management Office

Ivan P. Walrath, MS

Panelist

Ivan P. Walrath, MS

Pfizer Inc, United States

Process Owner, Trial Master File

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.